Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05330780 · ClinicalTrials.gov registry record · NA
Breathing Room Intervention to Achieve Better Lung Health in Older Adults
A NA study of Aging and Breathing, sponsored by University of Wisconsin, Milwaukee.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
- 1
- Study location
NCT05330780: Completed NA study of Aging and Breathing, sponsored by University of Wisconsin, Milwaukee.
NCT05330780 is a NA study of Aging and Breathing that has completed, run by University of Wisconsin, Milwaukee. The registered enrollment target is 46 participants, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05330780, a NA study of Aging and Breathing, has completed, sponsored by University of Wisconsin, Milwaukee.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
- 1
- Study location
Study Summary
This proposed study will evaluate whether a novel nonpharmacological intervention, Breathing Room, can improve lung function in the target population of older adults. Therefore, the primary aim of this pilot is to examine the effect of Breathing Room on inspiratory muscle strength, spirometry confirmed ventilatory function (Forced Expiratory Volume in one second (FEV1), Forced Vital Capacity (FVC) and FEV1/FVC), functional status, posture, physical activity, and lower respiratory infection rates.
Primary Outcome
Spirometry testing will be performed using the MicroLoop battery operated portable spirometer to assess changes in forced expiratory volume in one second (FEV1) pre and post intervention
Interventions
- OTHER Breathing Room
Study Locations (1)
Wisconsin
- Ovation Communities (Jewish Home/Chai Point) - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2022-02-22 |
| Est. Completion | 2023-11-29 |
| Phase | NA |
What the finished NCT05330780 record still lists
NCT05330780 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Aging appearing as the primary indexed condition, and to 1 intervention - of which Breathing Room is the first listed.
NCT05330780 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT05330780 about?
NCT05330780 is a clinical study titled "Breathing Room Intervention to Achieve Better Lung Health in Older Adults". This proposed study will evaluate whether a novel nonpharmacological intervention, Breathing Room, can improve lung function in the target population of older adults. Therefore, the primary aim of this pilot is to examine the effect of Breathing Room on inspiratory muscle strength, spirometry confir...
What is the current status of trial NCT05330780?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2022-02-22. Estimated completion is 2023-11-29.
What conditions does trial NCT05330780 study?
This clinical trial studies the following conditions: Aging, Breathing.
What interventions are being tested in trial NCT05330780?
The interventions under investigation include: Breathing Room (OTHER).
Who is sponsoring clinical trial NCT05330780?
This trial is sponsored by University of Wisconsin, Milwaukee, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05330780 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05330780's enrollment target sits among peer trials
46 161st of 262 higher than 98 of 262 other Aging trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Using Nicotine to Reverse Age-related Auditory Processing Deficits
RECRUITING · NA
-
Heterogeneity of Vascular Adaptations to Exercise With Aging in Women and Men
RECRUITING · NA
-
Modulating Neurocognitive Processes of Learning to Trust and Distrust in Aging
RECRUITING · NA
-
Studying the Effects of Digital Interventions on Cognition, Wellbeing, Stress, and Sleep in Older Adults
RECRUITING · NA
-
The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in Normal Aging Adults Who Are High-Risk Alcohol Drinkers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI